North Star Investment Management Corp. Grows Stake in PetMed Express, Inc. (NASDAQ:PETS)

North Star Investment Management Corp. lifted its holdings in PetMed Express, Inc. (NASDAQ:PETS) by 22.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,842 shares of the company’s stock after buying an additional 17,501 shares during the quarter. North Star Investment Management Corp. owned 0.47% of PetMed Express worth $4,361,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the stock. Pinebridge Investments L.P. lifted its position in shares of PetMed Express by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock valued at $110,000 after acquiring an additional 27 shares in the last quarter. Acrospire Investment Management LLC acquired a new position in PetMed Express in the second quarter valued at $110,000. Sei Investments Co. increased its stake in PetMed Express by 50,142.9% in the third quarter. Sei Investments Co. now owns 3,517 shares of the company’s stock valued at $117,000 after purchasing an additional 3,510 shares during the last quarter. Fred Alger Management Inc. acquired a new position in PetMed Express in the second quarter valued at $162,000. Finally, Thompson Siegel & Walmsley LLC acquired a new position in PetMed Express in the third quarter valued at $149,000. Hedge funds and other institutional investors own 99.88% of the company’s stock.

In related news, Director Gian Fulgoni sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $44.38, for a total value of $887,600.00. Following the sale, the director now directly owns 55,900 shares in the company, valued at approximately $2,480,842. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Menderes Akdag sold 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $51.00, for a total value of $1,530,000.00. Following the completion of the sale, the chief executive officer now owns 490,000 shares in the company, valued at $24,990,000. The disclosure for this sale can be found here. Insiders have sold a total of 51,000 shares of company stock worth $2,453,170 over the last quarter. Insiders own 4.00% of the company’s stock.

Several equities research analysts have commented on the company. Credit Suisse Group restated an “underperform” rating and set a $19.00 price target on shares of PetMed Express in a research note on Monday, October 2nd. ValuEngine lowered PetMed Express from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Zacks Investment Research downgraded PetMed Express from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 25th. Northcoast Research set a $58.00 target price on PetMed Express and gave the stock a “buy” rating in a research report on Wednesday, January 3rd. Finally, BidaskClub raised PetMed Express from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 9th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $42.80.

Shares of PetMed Express, Inc. (NASDAQ PETS) traded down $0.17 on Thursday, reaching $50.71. The company had a trading volume of 199,802 shares, compared to its average volume of 540,591. PetMed Express, Inc. has a 1 year low of $19.21 and a 1 year high of $53.90. The stock has a market capitalization of $1,050.00, a P/E ratio of 34.03, a P/E/G ratio of 3.08 and a beta of 1.12.

PetMed Express (NASDAQ:PETS) last released its earnings results on Monday, October 23rd. The company reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.13. The company had revenue of $66.70 million for the quarter, compared to the consensus estimate of $63.41 million. PetMed Express had a return on equity of 31.46% and a net margin of 11.58%. PetMed Express’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.24 EPS. equities research analysts expect that PetMed Express, Inc. will post 1.68 EPS for the current year.

TRADEMARK VIOLATION WARNING: This story was originally posted by Week Herald and is the sole property of of Week Herald. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at https://weekherald.com/2018/01/18/north-star-investment-management-corp-acquires-17501-shares-of-petmed-express-inc-pets.html.

PetMed Express Company Profile

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply